octnov2013
Pom Wonderful sued Coca-Cola in 2007, claiming the label on its pomegranate blueberry juice was misleading because the product is 99 percent apple and […]
In June 2013, the U.S. Supreme Court released its decision on “reverse payment” settlements between brand-name and generic drug makers. Federal Trade Commission v. […]
A provision in the Manual of Patent Examining Procedure arguably broadens the duty to provide information that is material to patentability in respect to […]
The Internet is undergoing a significant makeover with the rollout of hundreds of new generic Top Level Domains (gTLDs). They will create a vastly […]
Advanced technology companies today are essentially choosing to appropriate other companies’ technology rather than doing their own R&D, according to the author. They don’t […]
As a result of the increase in global commerce and international corporate disputes, discovery of large volumes of data in litigation is becoming common […]
Developing a jury-friendly trial strategy in a patent case is critical to success. Reflecting on their medical device jury trial experience, the authors focus […]
Recent legislative and regulatory actions by states and municipalities, and new efforts by the EEOC, are restricting consideration of criminal records in the hiring […]
In a recent Delaware Chancery Court decision (Boilermakers Local 154 Retirement Fund, et al. v. Chevron Corporation and IClub Investment Partnership v. FedEx Corporation, […]
There are three major mistakes made by compensation committees in hiring a new CEO: failure to set a compensation range before commencing the search, […]